Noosa News
Brisbane company wins European approval for rapid COVID-19 tests
A Brisbane-based firm has won approval from European regulators to sell its 15-minute COVID-19 rapid test.
The company, AnteoTech, has been given the Conformitè Europëenne Mark registration for its antigen rapid test, EuGeni.
AnteoTech chief executive Derek Thomson.
The reusable test, which now meets crucial health and safety conditions in Europe and the United Kingdom, is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the…
-
General16 hours agoJudge declares mistrial on one of three Harvey Weinstein rape charges
-
General18 hours agoChinese captain jailed for three years for cutting an undersea cable off Taiwan
-
General15 hours agoTrump to drive a hard bargain with PM over subs deal
-
General24 hours agoThe Left are undermining our defence relationship with America